Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890357 · ClinicalTrials.gov registry record
Identifying Factors Underlying the Discontinuation of Triptans
A clinical trial of Migraine and Medication Adherence, sponsored by Mayo Clinic.
- Completed
- Registry status
- 292
- Enrollment target
- 3
- Study locations
NCT00890357: Completed study of Migraine and Medication Adherence, sponsored by Mayo Clinic.
NCT00890357 is a study of Migraine and Medication Adherence that has completed, run by Mayo Clinic. The registered enrollment target is 292 participants, below the 355-participant average among 102 other Migraine trials with a reported enrollment target (18% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00890357, a study of Migraine and Medication Adherence, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 292 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.
Conditions Studied
Study Locations (3)
Florida
- University of South Florida College of Medicine - Tampa
Missouri
- Washington University School of Medicine - St Louis
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-06 |
What the finished NCT00890357 record still lists
NCT00890357 is an observational study that tracks outcomes without assigning an intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 355-participant average among 102 other Migraine trials with a reported enrollment target (18% lower).
The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 0 interventions.
NCT00890357 reports a single indexed study location in Florida, Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT00890357 about?
NCT00890357 is a clinical study titled "Identifying Factors Underlying the Discontinuation of Triptans". The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.
What is the current status of trial NCT00890357?
This trial is currently completed. The enrollment target is 292 participants. The study started on 2009-08. Estimated completion is 2012-06.
What conditions does trial NCT00890357 study?
This clinical trial studies the following conditions: Migraine, Medication Adherence.
Who is sponsoring clinical trial NCT00890357?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00890357 being conducted?
This trial has 3 study locations across Florida, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00890357's enrollment target sits among peer trials
292 33rd of 102 higher than 70 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Migraine Manager (R01)
RECRUITING · Phase 2
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
RECRUITING
-
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
RECRUITING · Phase 3
-
Mechanistic Studies of Psilocybin in Headache Disorders
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- NCT05406622 · 292 participants · NA
MOTIV BTK Randomized Controlled Trial
- NCT05757102 · 292 participants · Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- NCT06569667 · 292 participants · NA
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia